Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Has announcements × Adenocarcinoma × zolbetuximab × Clear all

Phase

Status

Active not recruiting 2

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 2 Neoplasms 2 Adenocarcinoma 2

Interventions

zolbetuximab 2 Oxaliplatin 2 Afatinib 2 trastuzumab deruxtecan 1 tepotinib 1 repotrectinib 1 pralsetinib 1 brigatinib 1 Standard of Care 1 Pemetrexed 1 Leucovorin 1 Fluorouracil 1 Crizotinib 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03504397 2026-02-13

Spotlight

Astellas Pharma Inc

Phase 3 Active not recruiting

565 enrolled 63 charts 1 FDA

Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms

NCT03653507 2026-02-06

GLOW

Astellas Pharma Inc

Phase 3 Active not recruiting

507 enrolled 65 charts 1 FDA

Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡